Finally, our study is the first one which investigated DPP4 activity and concentration in relation to the FIB-4 score, a broadly validated marker of liver fibrosis which play a central role in the diagnostic algorithm of NAFLD and NASH in high risk populations [36]. The gene discussed is DPP4; the disease is metabolic dysfunction-associated steatohepatitis.